Social Pulse: AMAG Pharmaceuticals Inc (AMAG.OQ)
AMAG.OQ on NASDAQ Stock Exchange Global Select Market
23.61USD
1 Aug 2013
23.61USD
1 Aug 2013
Price Change (% chg)
$1.11 (+4.93%)
$1.11 (+4.93%)
Prev Close
$22.50
$22.50
Open
$23.15
$23.15
Day's High
$23.72
$23.72
Day's Low
$22.92
$22.92
Volume
22,309
22,309
Avg. Vol
36,596
36,596
52-wk High
$25.63
$25.63
52-wk Low
$13.90
$13.90
- Keryx Biopharmaceuticals Presents An Attractive Investment Opportunity
- FDA Decisions: Interesting Biotechnology Catalyst Events
- Solid Showing At WCN Conference For Keryx: Catalysts Still To Come
- Keryx: Attractive In Front Of Catalyst-Rich Second Half
- 3 Horrendous Health-Care Stocks This Week
- A Review Of Upcoming Catalysts For Kidney Disease Biotech Players In 2013
Press Releases
- AMAG Pharmaceuticals Announces New Data from Ferumoxytol Pivotal Phase III Broad Iron Deficiency Anemia Program Presented at ASH
- AMAG Pharmaceuticals, Inc. to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
- AMAG Pharmaceuticals, Inc. Announces that Feraheme Abstracts for the American Society of Hematology Annual Meeting are Now Available
- Rienso (Ferumoxytol) Launched in Europe for the Treatment of Iron Deficiency Anemia in Adult Patients with Chronic Kidney Disease
- AMAG Pharmaceuticals Announces Financial Results for the Third Quarter and Nine Months Ended September 30, 2012

